Q1 Earnings Forecast for CATX Issued By Lifesci Capital
Perspective Therapeutics, Inc. (NYSE:CATX – Free Report) – Investment analysts at Lifesci Capital issued their Q1 2025 earnings per share (EPS) estimates for shares of Perspective Therapeutics in a report issued on Thursday, March 27th. Lifesci Capital analyst D. Kennedy expects that the company will earn ($0.28) per share for the quarter. Lifesci Capital currently […]
Perspective Therapeutics, Inc. (NYSE:CATX – Free Report) – Investment analysts at Lifesci Capital issued their Q1 2025 earnings per share (EPS) estimates for shares of Perspective Therapeutics in a report issued on Thursday, March 27th. Lifesci Capital analyst D. Kennedy expects that the company will earn ($0.28) per share for the quarter. Lifesci Capital currently […]
